Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China

Table 2 Adverse effect after the first and second doses of the vaccine

Characteristic	Healthy	Cancer	P value
Overall incidence	34.4% (74/215)	28.0% (37/132)	0.215
Tired	8.8% (19)	15.9% (21)	0.045
Headache	12.1% (26)	12.9% (17)	0.829
Local pain	17.2% (37)	9.1% (12)	0.035
Fever	10.7% (23)	7.6% (10)	0.336
Erythema	8.4% (18)	6.8% (9)	0.600
Myalgia	7.0% (15)	6.1% (8)	0.739
Diarrhea	5.1% (11)	5.3% (7)	0.939
Nausea	7.4% (16)	3.8% (5)	0.166
Chills	3.7% (8)	3.8% (5)	0.975